Dysosma versipellis Extract Inhibits Esophageal Cancer Progression through the Wnt Signaling Pathway

Yanchun Pu1, Ping Jin1, Lianghong Liu1

  • 1School of Pharmaceutical Sciences, Hunan University of Medicine, No. 492, Jinxi South Road, Huaihua, Hunan Province 418099, China.

Abstract

Insights

The extract of Dysosma versipellis, containing podophyllotoxin, effectively inhibits esophageal cancer cell growth and invasion. It promotes apoptosis by suppressing the Wnt signaling pathway, showing potential for clinical use.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Esophageal cancer remains a significant global health challenge.
  • Targeting specific cellular pathways is crucial for effective cancer treatment.
  • Dysosma versipellis is a plant with potential medicinal properties.

Purpose of the Study:

  • To evaluate the anti-cancer effects of Dysosma versipellis extract on esophageal cancer cells.
  • To elucidate the underlying mechanisms, particularly the Wnt signaling pathway.
  • To assess the potential of Dysosma versipellis as a therapeutic agent.

Main Methods:

  • In vivo studies using BALB/C nude mice with implanted esophageal cancer cells.
  • In vitro assays including MTT, flow cytometry, and Transwell for cell viability, apoptosis, and invasion.
  • Western blot analysis to detect Wnt, β-catenin, and p-GSK3β/GSK3β expression.

Main Results:

  • Dysosma versipellis extract significantly reduced tumor formation and mass in vivo.
  • In vitro, the extract inhibited cell viability and invasion while promoting apoptosis.
  • Expression of Wnt, β-catenin, and p-GSK3β/GSK3β was downregulated by the extract, particularly podophyllotoxin.

Conclusions:

  • Podophyllotoxin from Dysosma versipellis exhibits potent anti-esophageal cancer activity.
  • The extract functions by inhibiting cell viability and invasion and inducing apoptosis.
  • Inhibition of the Wnt signaling pathway is a key mechanism, suggesting therapeutic potential.